Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model

Vaccine

Volumn 22, Issue 2, 2003, Pages 244-249

  Servat, Alexandre ^a   Lutsch, Charles ^b   Delore, Valentine ^b   Lang, Jean ^b   Veitch, Keith ^b   Cliquet, Florence ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

^b SANOFI PASTEUR   (France)

Author keywords

Equine rabies immunoglobulin; Heat treated; Post exposure treatment

Indexed keywords

FAVIRAB; IMOGAM RAGE; IMORAB; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEAT TREATMENT; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RABIES; RODENT; SURVIVAL RATE; VIRUS STRAIN;

EID: 0242543133     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00559-0     Document Type: Article

References (22)

1. Hanlon C.A., Niezgoda M., Morrill P.A., Rupprecht C.E. The incurable wound revisited: progress in human rabies prevention. Vaccine. 19:2001;2273-2279.
2. Centers for Disease Control and Prevention. Human rabies prevention - United States, 1999. Recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend Rep 1999;48(RR-1):1-21.
3. WHO. Expert Committee on Rabies. Eighth report. WHO Tech Rep Ser 1992;824:1-84.
4. WHO. Consultation on intradermal application of human rabies vaccines. Geneva, 13-14 March 1995. Wkly Epid Rec 1995;47:336-7.
5. Lang J., Attanath P., Quiambao B.et al. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Acta Trop. 70:1998;317-333.
6. Bahmanyar M., Fayaz A., Nour-Salehi S. Successful protection of humans exposed to rabies infection postexposure treatment with the new human diploid cell rabies vaccine and anti-rabies serum. JAMA. 236(24):1976;2751-2754.
7. Khawplod P., Wilde H., Chomchey P.et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine. 14(5):1996;389-391.
8. Dean D., Baer G. Studies on the local treatment of rabies infected wounds. Bull. WHO. 28:1963;477-483.
9. Loofbourof J., Cabasso V., Roby R., Anuskiewicz W. Human rabies immune globulin trials and dose determination. JAMA. 224:1973;871-874.
10. Cabasso VJ. Local wound treatment and passive immunization. In: Baer GM, editor. The natural history of rabies. Boston: CRC Press; 1991. p. 531-51.
11. Karliner J. Incidence of reactions following administration of anti-rabies serum - study of 526 cases. JAMA. 193(5):1965;359-362.
12. Wilde H., Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am. J. Trop. Med. Hyg. 42:1990;175-178.
13. Fayaz A. 20 years of rabies post-exposure treatment with cell culture rabies vaccines in Iran (1975-1995). WHO consultation of human rabies post-exposure treatment. Geneva, 3-5 March 1996.
14. Perrin P., Jacob Y., Aguilar-Sétien A.et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine. 18:2000;479-486.
15. Cliquet F., Aubert M., Sagne L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Meth. 212:1998;79-87.
16. Chomchay P., Khawplod P., Wilde H. Neutralizing antibodies to rabies following injection of rabies immune globulin into gluteal fat or deltoid muscle. J. Travel Med. 7:2000;187-188.
17. Saesow N., Chaiwatanarat T., Mitmoonpitak C., Wilde H. Diffusion and fate of intramuscularly injected human rabies immune globulin. Acta Trop. 76:2000;289-292.
18. Morimoto K., Hooper D.C., Spitsin S., Koprowski H., Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73:1999;510-518.
19. Murphy F.A. Rabies pathogenesis. Brief review. Arch. Virol. 54:1977;279-297.
20. Hanlon C.A., Niezgoda M., Rupprecht C.E. Postexposure prophylaxis for prevention of rabies in dogs. Am. J. Vet. Res. 63:2002;1096-1100.
21. Louie R.E., Dobkin M.B., Meyer P.et al. Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test. J. Biol. Stand. 3:1975;365-373.
22. Lyng J. Calibration of a replacement preparation for the international standard for rabies immunoglobulin. Biologicals. 22:1994;249-255.